Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients

Doyle, Adam; Gorgen, Andre; Muaddi, Hala; Aravinthan, Aloysious D.; Issachar, Assaf; Mironov, Oleg; Zhang, Wei; Kachura, John; Beecroft, Robert; Cleary, Sean P.; Ghanekar, Anand; Greig, Paul D.; McGilvray, Ian D; Selzner, Markus; Cattral, Mark S.; Grant, David R.; Lilly, Leslie B.; Selzner, Nazia; Renner, Eberhard L.; Sherman, Morris; Sapisochin, Gonzalo

doi:10.1016/j.jhep.2018.12.027

All Outputs (3)

Donor outcomes in anonymous live liver donation (2019)
Journal Article

Background Death rates on liver transplant waiting lists range from 5%-25%. Herein, we report a unique experience with 50 anonymous persons who volunteered to address this gap by offering to donate part of their liver to a recipient with whom they h... Read More about Donor outcomes in anonymous live liver donation.

The impact of preexisting and post-transplant diabetes mellitus on outcomes following liver transplantation (2019)
Journal Article

Background: Diabetes mellitus (DM) is said to adversely affect transplant outcomes. The aim of this study was to investigate the impact of pre-existing and post-transplant DM on liver transplant (LT) recipients. Method: A single centre retrospective... Read More about The impact of preexisting and post-transplant diabetes mellitus on outcomes following liver transplantation.

Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients (2019)
Journal Article

© 2019 European Association for the Study of the Liver Background & Aims: Radiofrequency ablation (RFA) is an effective treatment for single hepatocellular carcinoma (HCC) ≤3 cm. Disease recurrence is common, and in some patients will occur outside t... Read More about Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients.